These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16463687)

  • 1. MR features of regenerative nodules and dysplastic nodules in the cirrhotic liver.
    Xu H; Kong X; Xiong Y; Zhang X
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):601-3. PubMed ID: 16463687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI.
    Chou CT; Chen RC; Chen WT; Lii JM
    J Chin Med Assoc; 2011 Feb; 74(2):62-8. PubMed ID: 21354082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
    Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
    PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver.
    Rode A; Bancel B; Douek P; Chevallier M; Vilgrain V; Picaud G; Henry L; Berger F; Bizollon T; Gaudin JL; Ducerf C
    J Comput Assist Tomogr; 2001; 25(3):327-36. PubMed ID: 11351179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
    Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
    Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.
    Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
    Medicine (Baltimore); 2017 Jul; 96(29):e7278. PubMed ID: 28723741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of gadoxetic acid-enhanced MR imaging to characterize atypical cirrhotic nodules detected on dynamic CT images.
    Chou CT; Wu WP; Chen CB; Su WW; Chen RC; Chen YL
    PLoS One; 2014; 9(10):e107869. PubMed ID: 25310817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
    Gatto A; De Gaetano AM; Giuga M; Ciresa M; Siciliani L; Miele L; Riccardi L; Pizzolante F; Rapaccini GL; Gasbarrini A; Giuliante F; Vecchio FM; Pompili M; Bonomo L
    Abdom Imaging; 2013 Aug; 38(4):736-44. PubMed ID: 22986351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging.
    Chou CT; Chou JM; Chang TA; Huang SF; Chen CB; Chen YL; Chen RC
    World J Gastroenterol; 2013 Nov; 19(42):7433-9. PubMed ID: 24259975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver.
    Inchingolo R; De Gaetano AM; Curione D; Ciresa M; Miele L; Pompili M; Vecchio FM; Giuliante F; Bonomo L
    Eur Radiol; 2015 Apr; 25(4):1087-96. PubMed ID: 25430005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
    Joo I; Kim SY; Kang TW; Kim YK; Park BJ; Lee YJ; Choi JI; Lee CH; Park HS; Lee K; Kim H; Yu E; Kang HJ; Ha SY; Kim JY; Ahn S; Jung ES; Kim BH; Han HS; Lee JM
    Radiology; 2020 Aug; 296(2):335-345. PubMed ID: 32484414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation.
    Krinsky GA; Israel G
    AJR Am J Roentgenol; 2003 Apr; 180(4):1023-7. PubMed ID: 12646448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of focal hepatic lesions with SPIO-enhanced MRI.
    Zheng WW; Zhou KR; Chen ZW; Shen JZ; Chen CZ; Zhang SJ
    World J Gastroenterol; 2002 Feb; 8(1):82-6. PubMed ID: 11833077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.